Figure 5.
CT changes on week 8 (day 56) of treatment. Response to combination of everolimus and sorafenib in CT at week 8 of study treatment showing changes according to RECIST 1.1
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.